Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Colorcon
Boehringer Ingelheim
Dow
McKesson

Last Updated: January 24, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Ketanserin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Ketanserin?

Ketanserin is an investigational drug.

There have been 9 clinical trials for Ketanserin. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.

The most common disease conditions in clinical trials are Foot Ulcer, Diabetic Foot, and Shock, Septic. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Gitte Moos Knudsen, and Psychiatric University Hospital, Zurich.

Recent Clinical Trials for Ketanserin
TitleSponsorPhase
Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of ConsciousnessUniversity Hospital, Basel, SwitzerlandPhase 1
Effect of Ketanserin After LSD AdministrationUniversity Hospital, Basel, SwitzerlandPhase 1
Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study)Matthias LiechtiEarly Phase 1

See all Ketanserin clinical trials

Clinical Trial Summary for Ketanserin

Top disease conditions for Ketanserin
Top clinical trial sponsors for Ketanserin

See all Ketanserin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Colorcon
Boehringer Ingelheim
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.